This federal contract award, with ID SPE2DB22D1002|SPE2DB25FKWC2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,814,424 units of Ondansetron ODT 4 mg tablets. It is a firm-fixed-price delivery order contract with a ceiling value of $5,550.13 and a completion date of January 2, 2025. This contract award is not designated with a set-aside requirement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 4/1/25, 10:53 AM